4-((2-chlorophenyl)amino)-6-((5-hydroxypyridin-2-yl)amino)nicotinamide

ID: ALA5268459

Chembl Id: CHEMBL5268459

Max Phase: Preclinical

Molecular Formula: C17H14ClN5O2

Molecular Weight: 355.79

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)c1cnc(Nc2ccc(O)cn2)cc1Nc1ccccc1Cl

Standard InChI:  InChI=1S/C17H14ClN5O2/c18-12-3-1-2-4-13(12)22-14-7-16(21-9-11(14)17(19)25)23-15-6-5-10(24)8-20-15/h1-9,24H,(H2,19,25)(H2,20,21,22,23)

Standard InChI Key:  BDFXWFUXDCODKM-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5268459

    ---

Associated Targets(Human)

JAK1 Tclin JAK1/TYK2 (259 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin JAK3/JAK1 (270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK1 Tclin Tyrosine-protein kinase JAK1 (8569 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TYK2 Tclin Tyrosine-protein kinase TYK2 (5029 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 355.79Molecular Weight (Monoisotopic): 355.0836AlogP: 3.42#Rotatable Bonds: 5
Polar Surface Area: 113.16Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.63CX Basic pKa: 6.06CX LogP: 4.06CX LogD: 4.04
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.56Np Likeness Score: -0.99

References

1. Thoma G, Vangrevelinghe E, Luneau A, Piechon P, Beerli C, Zerwes HG..  (2023)  Novel Concept for Super-Soft Topical Drugs: Deactivation by an Enzyme-Induced Switch into an Inactive Conformation.,  14  (6): [PMID:37312861] [10.1021/acsmedchemlett.3c00169]

Source